 |
 |
 |
|
Sub-Study 202094 of SWORD-1 and SWORD-2: Switch From TDF-Containing Regimen to DTG + RPV Improves Bone Mineral Density and Bone Turnover Markers Over 48 Weeks
|
|
|
Reported by Jules Levin
9th IAS Conference on HIV Science; July 23-26, 2017; Paris, France
G McComsey,1 J Gonzalez-Garcia,2S Lupo,3J Dewet,4D Parks,5L Kahl,6B Wynne,7M Gartland,8K Angelis,9M Cupo,10K Vandermeulen,11M Aboud6
1University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH, USA; 2Hospital Universitario La Paz/IdiPAZ, Madrid, Spain; 3CAICA Institute, Rosario, Argentina; 4Spectrum Health, Vancouver, BC, Canada; 5Central West Clinical Research, St Louis, MO, USA; 6ViiV Healthcare, Brentford, UK; 7ViiV Healthcare, Collegeville, PA, USA; 8ViiV Healthcare, Research Triangle Park, NC, USA; 9GlaxoSmithKline, Uxbridge, UK; 10GlaxoSmithKline, Collegeville, PA, USA; 11Janssen, Beerse, Belgium




|
|
|
 |
 |
|
|